Iatrogenic immunodeficiency-associated lymphoproliferative disease of the Hodgkin lymphoma-like variant in a patient treated with mycophenolate mofetil for autoimmune hepatitis-Reference-Cited by-同舟云学术

Iatrogenic immunodeficiency-associated lymphoproliferative disease of the Hodgkin lymphoma-like variant in a patient treated with mycophenolate mofetil for autoimmune hepatitis

Published:2010-05-03 Issue:8 Volume:85 Page:627-629
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Adams Betsy,Lazarchick John,Medina Ana Maria,Willner Ira R.,Neville Brad,Murphy Edward,Stuart Robert,Costa Luciano J.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.21753/fullpdf

Reference19 articles.

1. Immunodeficiency-associated lymphoproliferative disorders;Knowles;Mod Pathol,1999

2. Malignant lymphomas associated with immunodeficiency states;Biemer;Ann Clin Lab Sci,1990

3. Brief report: Reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis;Kamel;N Engl J Med,1993

4. Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate;Ellman;J Rheumatol,1991

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Iatrogenic immunodeficiency-associated lymphoproliferative disorder presenting as small bowel perforation;BMJ Case Reports;2024-03

2. Characteristics and Outcomes of Alberta Lymphoma Patients with a History of Immunosuppressive therapy for Autoimmune Conditions;Clinical Lymphoma Myeloma and Leukemia;2022-12

3. Mycophenolate Mofetil-induced Diffuse Large B-cell Lymphoma in Which a Solitary Lung Nodule Remitted Spontaneously;Internal Medicine;2021-01-01

4. Iatrogenic immunodeficiency-associated lymphoproliferative disorder in a child with B-cell acute lymphoblastic leukemia;Pediatric Hematology and Oncology;2019-07-04

5. Epstein Barr Virus Associated B-Cell Lymphomas and Iatrogenic Lymphoproliferative Disorders;Frontiers in Oncology;2019-03-07